GAM Holding’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
CS
GAM Holding's BLUE Position: Q4 2020 in Review
GAM Holding sold out of bluebird bio (BLUE) in Q4 2020, closing a stake of 2,270 shares — an estimated $1.59M sold.
GAM Holding first reported a position in BLUE in Q3 2013 and held it in 21 quarters. The position peaked at $7.8M in Q1 2019. 262 funds tracked by Wall St. Rank hold BLUE as of Q4 2020.
- GAM Holding reported no remaining bluebird bio position as of Q4 2020 after selling out during the quarter.
- GAM Holding sold 2,270 bluebird bio shares in Q4 2020, an estimated $1.59M.
- GAM Holding first reported a position in bluebird bio in Q3 2013 and held it in 21 quarters.
- GAM Holding's bluebird bio position peaked at $7.8M in Q1 2019.
- 262 funds tracked by Wall St. Rank held bluebird bio as of Q4 2020.
Based on GAM Holding's 13F filing for Q4 2020, filed 10 Feb 2021.